A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Using the patent term changes in assessing the evolution of patent valuation from filing to maturity
2016
European Journal of Innovation Management
We argue that the patent term change introduced in TRIPS in the US inadvertently offered a metric of self-valuation of patents at the time of filing, affirming the ability of Drugs and Chemical patents to offer greater R&D incentives than other technology fields. As renewals also offer a metric of self-valuation, we find that upon renewal Computer patents are found to offer greater R&D incentives than Drugs and Chemicals. We inquire as to why Computer patents are considered as more valuable in
doi:10.1108/ejim-04-2015-0027
fatcat:hjtpuvuhxjaengrh6lr3z4ikzi